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PreeclampsiaAbstract Background: Albumin to creatinine ratio (ACR) in random urine samples correlates
well with 24-h protein excretion in potential glomerulopathy as in diabetic renal microangiopathy.
Using this ratio as an appropriate screening test for proteinuria or for the disease severity in hyper-
tensive disorders with pregnancy needs still to be veriﬁed.
Objective: To investigate the role of albumin to creatinine ratio in a random urine sample for
assessment of severity of preeclampsia.
Patients & methods: Two separate groups, ﬁfty women each, were enrolled. All were pregnant at
their third trimester with conﬁrmed preeclampsia. Based on their blood pressure levels, Group
A, included patients with mild form of preeclampsia, whereas group B included cases with severe
form. Albumin to creatinine ratio in random urine samples and the 24-h protein content in urine
were assessed.
Results: ACR and the 24-h urine protein excretion were signiﬁcantly correlated, (r= 0.583,
p< 0.001). Cut-off value for ACR for this group of patients was calculated to be 14.65 mg/mmol,
above which severity of the disease is highly probable. The sensitivity and speciﬁcity were 100% and
58.0%, respectively. The positive predictive value was 70.4% and negative predictive value was
100%.
Conclusions: Random urine ACR may be a reliable method for prediction and assessment of sever-
ity of preeclampsia. Using the estimated cut-off may add to the predictive value of such a simple
quick test.
ª 2014 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. All rights
reserved.t.
140 F.S. Moiety et al.1. Introduction
Hypertensive disorders complicating pregnancy are common
and form one of the deadly triad, along with hemorrhage and
infection that contribute greatly to maternal morbidity and
mortality.1,2 Preeclampsia is deﬁned as a pregnancy-speciﬁc
syndrome of reduced organ perfusion secondary to vasospasm
and endothelial activation.3–6 Proteinuria is an important sign
of preeclampsia, without which, the diagnosis is question-
able.7,8 Signiﬁcant proteinuria is deﬁned by 24-h urinary
protein exceeding 300 mg or persistent 30 mg/dl in random
urine samples. The degree of proteinuria may ﬂuctuate widely
over any 24-h period, even in severe cases. Therefore a
single random sample may fail to demonstrate signiﬁcant
proteinuria.9,10
Severe preeclampsia may be diagnosed clinically by persis-
tent diastolic hypertension at or above 110 mm Hg, marked
headache, visual symptoms, oliguria or right upper quadrant
pain. Persistent proteinuria and abnormal liver or renal func-
tion tests are all signs of disease severity as well.11
The measurement of protein excretion in a 24-h urine col-
lection is used as the gold standard for the diagnosis and fol-
low-up of pathologic urinary excretion.12 However, 24-h
urine collection is time consuming, inconvenient and often
inaccurate especially during pregnancy with less patient’s
compliance.
It is of utmost importance to highlight new diagnostic or pre-
dictive reliable tests, and hence introduce and apply them in a
population with still fairly high maternal mortality rate, such
as the Egyptian population. Many suggestions of predictors of
severity of preeclampsia in the Egyptian population have been
published, such as blood lead level,13 genetic mutation in Endo-
thelial nitric oxide synthase (eNOS) (Glu298Asp) or urotensin II
(UTS2 S89N) gene polymorphisms,14 and maternal serum
leptin.15
In this study we studied a random urine albumin to creat-
inine ratio as a simple quick test to predict the presence of sig-
niﬁcant proteinuria and to assess severity of preeclampsia in
Egyptian patients.Table 1 Albumin, creatinine, ACR and protein in urine.
Group A (Mild) n= 50
Albumin (mg/L)
Range 1.19–6500.00
Mean ± SD 717.99 ± 1273.03
Median 20.80
Creatinine (mmol/L)
Range 0.32–18.64
Mean ± SD 5.53 ± 4.76
Median 3.97
ACR (mg/mmol)
Range 0.31–980.39
Mean ± SD 140.36 ± 232.59
Median 4.59
Protein (mg/24-h)
Range 390.00–4410.00
Mean ± SD 1285.60 ± 945.14
Median 887.50
Z: Z for Mann Whitney test.
* Statistically signiﬁcant at p 6 0.05.2. Patients and methods
One hundred pregnant women attending the Antenatal clinic of
our University hospital were enrolled. All women were primi-
gravidae, at or above 28 weeks of gestation and with conﬁrmed
diagnosis of preeclampsia. Based on their blood pressure levels,
and after a full informed consent was signed, women were re-
cruited into two separate equal groups (50 women each); group
A, consisted of patients with mild form of preeclampsia (dia-
stolic blood pressure less than 110 mm Hg34) andGroup B con-
sisted of patients with severe form (diastolic blood pressure at or
above 110 mm Hg34). Patients with chronic hypertension, dia-
betes mellitus, preexisting renal or vascular disease or urinary
tract infection were excluded. The study was formally approved
by the Ethical Committee of the Faculty of Medicine, Alexan-
dria University with the following ID:[IRB No. 00006555,
FWA No. 00011712,May 2008]. Microalbumin in urine was
tested by NycoCard Microalbumin Single Test (Axis-Shield
plc, Oslo, Norway) based upon an immunometric ﬂow-through
principle. Quantitative determination of both creatinine and
albumin in urine sample was done by Roche/Hitachi 902
analyzer (Roche Diagnostics, Basel, Switzerland).16,17
The statistical analysis of the data obtained in the present
study was carried out using the Statistical Packages for the So-
cial Sciences (SPSS version 15.0, Chicago, IL). Normally dis-
tributed data were presented as mean, standard deviation,
whereas skewed data were expressed as median and range.
Pearson coefﬁcient of correlation was used to ﬁnd the correla-
tion between two parameters in the same group. ROC curve
was plotted to ﬁnd the diagnostic performance of the variables.
3. Results
The mean values of albumin (mg/L), creatinine (mmol/L),
ACR in a random urine sample, and 24-h protein in urine
(mg/24-h) in both groups are shown in Table 1. Signiﬁcant sta-
tistical differences were found between both studied groups
regarding albumin in random urine sample, ACR, and 24-hGroup B (Severe) n= 50 Z (p)
34.40–29500.00 6.613* (<0.001)
3976.97 ± 5580.22
2650.00
0.60–39.91 1.896 (0.058)
8.24 ± 7.86
5.54
14.85–2673.48 6.225* (<0.001)
631.62 ± 530.60
533.67
14.85–11850.00 6.894* (<0.001)
7066.08 ± 2795.22
7565.00
Figure 1 The correlation between ACR and the 24-h protein in urine.
Albumin to creatinine ratio in a random urine sample 141protein in urine, however, it was not signiﬁcantly different
when it came to creatinine in a random urine sample (Table 1).
There was a strong positive correlation between ACR and
the severity of preeclampsia when Spearman coefﬁcient was
applied (r= 0.518, p< 0.001), similarly, the correlation be-
tween ACR and the 24-h protein in urine was also found to
be signiﬁcantly positive (r= 0.583, p< 0.001) (Fig. 1).
Using the ROC curve, the cut-off value of ACR for the
study subjects was calculated to be 14.65. ACR above this va-
lue could be used as a good predictor for the disease severity,
with a sensitivity of 100% and a speciﬁcity of 58.0%. TheFigure 2 Receiver operating characteristic (ROC) curve com-
paring the diagnostic performance of ACR (dashed line) and
protein in 24-h urine (continuous line) (AUC) for ACR was 0.93
(AUC) for protein in 24-h urine was 0.89.positive predictive value was 70.4% and negative predictive va-
lue was 100%. The area under the curve (AUC) represented
the diagnostic performance of both 24-h urine protein, and
ACR. It conﬁrmed a better role for the latter (AUC 0.93)
(Fig. 2).
4. Discussion
Preeclampsia is associated with the highest risk of adverse
maternal and perinatal complications that affect 2–5% of
pregnancies.16 Assessing the presence or absence of signiﬁcant
proteinuria (P0.3 g/day) represents a key component in the
evaluation of pregnant women with hypertension. Urine col-
lection over 24 h is considered the traditional way for quanti-
ﬁcation of proteinuria in pregnancy, however, timed
collections delay clinical diagnosis and may result in prolonged
hospital stay, thereby increasing patient anxiety and healthcare
costs. Moreover, it requires more patients’ compliance than
could be usually found in pregnancy. Alternatives include: uri-
nary dipsticks, urine collections over a shorter period, the uri-
nary spot protein: creatinine ratio, and the urinary spot
albumin: creatinine ratio (ACR). The dipstick is inexpensive,
easy to use, and provides a rapid result but has low sensitivity
and speciﬁcity.18,17 Shorter timed urine collections (2, 4, 8, or
12 h) were also suggested to diagnose proteinuria in pregnancy
but still, they have their own limitations.18–20 The spot protein:
creatinine ratio and spot ACR have been well studied and
used. The National Kidney Foundation now recommends
these tests (instead of 24-h urine collection) to diagnose pro-
teinuria in most situations, without speciﬁc mention of
pregnancy.17 The Australasian Society for the Study of Hyper-
tension in Pregnancy and the International Society for the
Study of Hypertension in Pregnancy have proposed the use
of the urinary spot protein: creatinine ratio as an alternative
to 24 h urine collection.21–25 Up to our knowledge, the spot
protein: creatinine ratio is not widely used for the diagnosis
of proteinuria in pregnant women with hypertension. In our
study, it was shown that ACR is signiﬁcantly higher in patients
with severe preeclampsia than those with a mild form of the
disease. Moreover, the correlation between ACR and the
142 F.S. Moiety et al.24-h protein in urine was also found to be positive, indepen-
dent of gestational age, maternal age, blood chemistry or time
of disease onset. It was also possible, in the light of this work,
to calculate the cut-off value for ACR for the enrolled patients,
above which, a severe form of the disease might be predicted.
This is to our knowledge the ﬁrst report in Egypt, to recom-
mend such a test and a cut-off for diagnosis/follow up of albu-
minuria in pregnancy, which can, thus, be used as a marker of
severity of preeclampsia. Finally, a better diagnostic potential
for ACR than a 24-h urine protein, was suggested based on
our result analysis. In conclusion, ACR measurement is a sim-
ple, quick, and reasonably-reliable method for assessment of
severity of preeclampsia.Conﬂicts of interest
None.
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